Clinical trial · Interventional
Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors
NCT03581357CI-TRIAL-00069046completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluate the impact and satisfaction of Mobile Mindfulness Meditation on anxiety, pain, fatigue, trauma, and sleep in cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Other Than Non-melanoma Skin Cancer | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mindfulness Coach | Behavioral | — | UNRESOLVED |
| Mobile Mindfulness Meditation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- ACTIVE_COMPARATOR
- label
- Control/Waitlist (Anxiety Group)
- description
- Subjects assigned to this arm will not be offered access to the mobile app during the first 8 weeks of their participation. Subjects will be asked to begin using the app eight weeks after randomization. Subjects assigned to this arm will complete a questionnaire at three times points: the beginning after the subject has signed the informed consent form, at the 8 week time point (just before subject begins using the mobile app) and 16 week time point.
- interventionNames
- Behavioral: Mobile Mindfulness Meditation
- type
- ACTIVE_COMPARATOR
- label
- Mindfulness App (Anxiety Group)
- description
- Subjects assigned to this arm will receive mindfulness meditation instructions for 8 consecutive weeks following randomization to this arm. The mobile app contains 14 sessions that subject can participate in at their own pace. Subjects are asked to try and practice mindfulness meditation daily, for a total time of 2 hours per week. Subjects assigned to this arm will complete a questionnaire at three times points: the beginning after the subject has signed the informed consent form, at the 8 week and 16 week time points.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria Anxiety Arm: 1. previous diagnosis of cancer, other than non-melanoma skin cancer 2. over 21 years of age 3. routine access to the Internet 4. comfortable reading and writing in English 5. have completed primary treatment for cancer 6. indicate the presence of cancer related anxiety as indicated by the PROMIS measure 7. not currently practicing meditation regularly (more than one hour per week), and 8. diagnosed with any stage of cancer 9. own a smartphone or tablet Cancer Related Neuropathy Arm 1. diagnosis of cancer 2. use of a taxane or platinum agent 3. experiencing CIPN, per self-report 4. over 21 years of age 5. routine access to a smart device 6. comfortable reading and writing in English, and 7. not currently practicing meditation regularly (more than one hour per week). Exclusion Criteria: None
References
Publications (1)
- DERIVEDOrasud AS, Uchiyama M, Pagano I, Bantum E. Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Feb 12;13:e47745. doi: 10.2196/47745. PMID 38345843